Cytokinetics (CYTK) Shares Issued (2017 - 2024)
Historic Shares Issued for Cytokinetics (CYTK) over the last 14 years, with Q4 2024 value amounting to $3.0 million.
- Cytokinetics' Shares Issued fell 5056.55% to $3.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $53.0 million, marking a year-over-year increase of 18720.95%. This contributed to the annual value of $53.0 million for FY2024, which is 18720.95% up from last year.
- According to the latest figures from Q4 2024, Cytokinetics' Shares Issued is $3.0 million, which was down 5056.55% from -$43.6 million recorded in Q2 2024.
- Over the past 5 years, Cytokinetics' Shares Issued peaked at $93.6 million during Q1 2024, and registered a low of -$43.6 million during Q2 2024.
- In the last 5 years, Cytokinetics' Shares Issued had a median value of $3.6 million in 2022 and averaged $9.0 million.
- Data for Cytokinetics' Shares Issued shows a peak YoY increase of 253997.74% (in 2024) and a maximum YoY decrease of 86736.42% (in 2024) over the last 5 years.
- Cytokinetics' Shares Issued (Quarter) stood at $34.2 million in 2020, then tumbled by 55.75% to $15.1 million in 2021, then plummeted by 76.24% to $3.6 million in 2022, then surged by 69.57% to $6.1 million in 2023, then tumbled by 50.57% to $3.0 million in 2024.
- Its last three reported values are $3.0 million in Q4 2024, -$43.6 million for Q2 2024, and $93.6 million during Q1 2024.